Interestingly, serum IGF1 was strongly correlated positively with male gender (r = 0.714, P = 0.01) and negatively with LN metastasis and tumor stage (r = − 0.77, P = 0.006 for each) among the non-obese CRC patients. This evidence concerns the gene IGF1 and colorectal carcinoma.